Tradestie Institutional Equity Comparison Engine

GFR vs EPSN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EPSN Overall Edge

EPSN Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Epsilon Energy Ltd. (EPSN) driven by superior Growth & Margin, Options & Structure while GFR counters with relative strength in Valuation, Momentum & Technical. Fundamentally, GFR trades at 9.5x Forward P/E with -1.1% operating margin (+97.7% YoY revenue) versus EPSN at 15.6x Forward P/E and 24.6% operating margin (+57.1% YoY). In options structure, GFR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EPSN sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GFR
GFR 9.5x vs EPSN 15.6x Fwd P/E
Growth & Margin Winner EPSN
Op Margin -1.1% vs 24.6% ยท YoY +97.7% vs +57.1%
Momentum & Technical Winner GFR
1Y +50.4% vs +0.8% ยท 52W Pos 95% vs 24%
Options & Structure Winner EPSN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (13th %ile IV)
GFR NYSE
Greenfire Resources Ltd.
Crude Petroleum & Natural Gas
$7.64
-0.39% 1D
Market Cap $1.8B
1M Return +14.54%
1Y Return +50.39%
Forward P/E 9.5x
Unified AI Score
31.3 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 44.0
EPSN NASDAQ
Epsilon Energy Ltd.
Crude Petroleum & Natural Gas
$4.80
-3.03% 1D
Market Cap $149.9M
1M Return -22.08%
1Y Return +0.84%
Forward P/E 15.6x
Unified AI Score
41.6 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GFR +50.39% EPSN +0.84% Spread: +49.55 pp (GFR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GFR TTM Op. Margin: -1.1% EPSN TTM Op. Margin: 24.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GFR vs EPSN. Trailing 12-month operating profitability (GFR -1.1% vs EPSN 24.6%) and valuation multiples (GFR 9.5x vs EPSN 15.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GFR (5) vs EPSN (5)
Institutional Metric GFR EPSN Criterion Row Winner
Market Capitalization Scale $1.8B $149.9M Larger Scale GFR
Trailing P/E Ratio Valuation 8.4x 15.6x Lower Multiple GFR
Forward P/E Ratio Valuation 9.5x 15.6x Lower Multiple GFR
Revenue Growth (YoY) Growth +97.7% +57.1% Higher Growth GFR
Operating Margin (TTM) Profitability -1.1% 24.6% Higher Margin EPSN
Net Profit Margin Profitability -6.9% -5.2% Higher Margin EPSN
Return on Equity (ROE) Capital Efficiency -3.5% -3.0% Higher ROE EPSN
52-Week Range Position Momentum 95% ($4โ€“$8) 24% ($4โ€“$7) Stronger Trend GFR
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 140% Vol -0.31ฮฒ ยท 43% Vol Lower Realized Risk EPSN
Unified Institutional Score Composite Signal 31.3 / 100 (SELL) 41.6 / 100 (SELL) Higher Composite EPSN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GFR vs EPSN Buy Guide
GFR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GFR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EPSN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live EPSN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GFR nor EPSN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.